3 Areas of Opportunity for Private Equity Investment in Life Sciences

Overview




The life sciences investment space has been largely immune to the negative impacts of the COVID-19 pandemic. Growth in the pharmaceutical, biotechnology and medical device industries has led to increased interest from private equity investors, many of which are new to the life sciences market.

In this video we address:

  • Three areas ripe for private equity investment in the life sciences arena
  • Sector-specific due diligence concerns investors should address
  • Opportunities for ROI when investing in life sciences and life sciences adjacent companies

Dig Deeper

Webinar / American Conference Institutes (ACI) / September 29-30, 2021

ACI's FDA Boot Camp

Webinar / Momentum Events / September 13-14, 2021

Momentum Events: Strategy Summit on Paragraph IV Litigation

Webinar / McDermott Event / July 26, 2021

Exploring Consumer Engagement with Precision Medicine

Webinar / McDermott Event / July 15, 2021

340B... or Not 340B: Oversight, Compliance and Enforcement

Get In Touch